Indian regulator okays 3 indigenous monkeypox kits

New Delhi, August 29 India today took a significant step in combating monkeypox with apex drug regulator granting manufacturing licenses for real-time diagnosis to three indigenously developed in vitro kits. RT-PCR kits for Mpox virus have been developed by three...

Tribune News Service

Updated At : 07:18 AM Aug 30, 2024 IST

New Delhi, August 29

India today took a significant step in combating monkeypox with apex drug regulator granting manufacturing licenses for real-time diagnosis to three indigenously developed in vitro kits.

RT-PCR kits for Mpox virus have been developed by three Indian firms in collaboration with the ICMR. The World Health Organisation (WHO) has declared Mpox as a public health emergency of international concern.

The Indian firms are Siemens Healthcare, Transasia Diagnostics and JITM C Genes.

Indian regulator okays 3 indigenous monkeypox kits

Tribune News Service

Live Matches